Metformina come terapia di mantenimento in sarcomi ossei ad alto rischio di ricaduta

Title

Code

Metformina-Bone

Type

Sperimentale

Start Year

2021

Status

In Corso

Principal Investigator

051-6445516

alessandra.longhi@ior.it

Longhi Alessandra, MD

Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies

Operational unit that carry out the study

complex unit

Osteoncologia, Sarcomi dell'osso e dei tessuti molli, e Terapie Innovative

Director

Ibrahim Toni, BSc, MSc, MD, PhD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. Metformina-Bone

Thursday 11 August 2022, 14:48

Metformina-Bone.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Metformina come terapia di mantenimento in sarcomi ossei ad alto rischio di ricaduta

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Metformina come terapia di mantenimento in sarcomi ossei ad alto rischio di ricaduta

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in